Claris Lifesciences (Delisted) share news and announcements

BSE: 533288

Last traded ₹396.55 on 14 Mar 2018

Delisted on 22 Mar 2018.

Claris Lifesciences share news and announcements

337 announcements, routine notices left out, newest first. Page 6 of 7.

Mar 2013
- 28 Mar · Meeting
  Register of Members & Share Transfer Books of the Company will remain closed from April 08, 2013 to April 12, 2013 (both days inclusive) ....
Feb 2013
- 25 Feb · Claris Lifesciences received ANDA approvals for Ondensetron Inj. in US
  Press Release dated February 25, 2013, titled "Claris Lifesciences received ANDA approvals for Ondensetron Inj. in US" (opens in a new tab)
- 23 Feb · Dividend
  Board of Directors of the Company at its meeting held on February 23, 2013, inter alia, has approved the following resolutions, subject ....
- 23 Feb · Results
  Financial Results & a copy of Results Press Release for the period ended December 31, 2012. (opens in a new tab)
- 18 Feb · Meeting
  Members of the Company have passed the Resolutions by way of Postal Ballot. (opens in a new tab)
- 13 Feb · Board meeting
  Meeting of the Board of Directors of the Company will be held on February 23, 2013, inter alia, to consider and take on record the annual ....
Jan 2013
- 21 Jan · Results
  Company will going to publish annual audited financial results for the year ended December 31, 2012 within a period of 60 days from the ....
- 9 Jan · Meeting
  Members of the Company will consider to approve the resolutions, by way of Postal Ballot. (opens in a new tab)
- 4 Jan · Disclosure
  Arum Investments Pvt Ltd has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 (opens in a new tab)
- 2 Jan · Disclosure
  Aditya Handa has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 2 Jan · Disclosure
  Aditya Handa has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
Dec 2012
- 13 Dec · Business
  Press Release dated December 13, 2012. Press Release: "Claris Lifesciences Limited, India (Claris) has further elaborated .... (opens in a new tab)
- 7 Dec · Business
  Press Release dated December 07, 2012 titled "Claris Lifesciences Ltd., enters into a joint venture with Otsuka Pharmaceutical Factory, .... (opens in a new tab)
- 7 Dec · Board meeting
  Board of Directors of the Company at its meeting held on December 07, 2012 has granted approval to the Company for entering into definitive ....
- 4 Dec · Demise of Independent & Non Executive Chairman
  Dr. Pravin P. Shah, an Independent and Non-Executive Chairman of the Company have passed away last late night.
Nov 2012
- 29 Nov · Disclosure
  Aditya Handa has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 16 Nov · Disclosure
  Aditya Handa has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 13 Nov · Disclosure
  Arum Investments Pvt Ltd has submitted the disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 (opens in a new tab)
- 12 Nov · Disclosure
  IDBI Trusteeship Services Ltd has submitted the disclosures under Reg. 29(1) / 29(2) of SEBI (SAST) Regulations, 2011 (opens in a new tab)
- 8 Nov · Disclosure
  Aditya Handa has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 8 Nov · Disclosure
  Medical Technologies Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 1 Nov · Board meeting
  Board of Directors of the Company at its meeting held on October 31, 2012, have considered and approved the resignation tendered by Mr. ....
Oct 2012
- 31 Oct · Limited Review for Sep 30, 2012
  Limited Review Report for the period ended September 30, 2012. (opens in a new tab)
- 31 Oct · Results
  Results Press Release dated October 31, 2012 for the period ended September 30, 2012. (opens in a new tab)
- 31 Oct · Results
  Financial Results for the period ended September 30, 2012. (opens in a new tab)
Sep 2012
- 24 Sep · Management
  Company has received a resignation letter from Mr. Nikhil Mohta, a Non-Executive Director on the board of the Company. Mr. Nikhil ....
Aug 2012
- 24 Aug · Claris to sell on its own in the US
  Press Release dated August 24, 2012 titled "Claris to sell on its own in the US" (For more details kindly refer Corporate Announcements .... (opens in a new tab)
- 21 Aug · Disclosure
  Claris Lifesciences Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 (opens in a new tab)
- 21 Aug · Disclosure
  Aditya S Handa has submitted the disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992 (opens in a new tab)
- 21 Aug · Claris Lifesciences receives Letter from the US FDA
  Press Release dated August 21, 2012 titled "Claris Lifesciences receives Letter from the US FDA". (For more details kindly refer Corporate .... (opens in a new tab)
- 17 Aug · Disclosure
  Aditya Handa has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 17 Aug · Disclosure
  Aditya Handa has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 16 Aug · Claris Lifesciences - Close Out Letter from the US FDA
  Press Release dated August 16, 2012 titled "Claris Lifesciences - Close Out Letter from the US FDA" Press Release: "Claris .... (opens in a new tab)
- 14 Aug · Disclosure
  Claris Lifesciences Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 (opens in a new tab)
- 14 Aug · Disclosure
  Aditya S Handa has submitted the disclosures under Reg.13(4), 13(4A) of SEBI (Prohibition of Insider Trading) Regulations, 1992 (opens in a new tab)
- 9 Aug · Limited Review for June 30, 2012
  Limited Review Report for the period ended June 30, 2012. (opens in a new tab)
- 9 Aug · Results
  Results Press Release dated August 09, 2012 for the period ended June 30, 2012. (opens in a new tab)
- 9 Aug · Results
  Financial Results for the period ended June 30, 2012. (opens in a new tab)
Jul 2012
May 2012
- 24 May · Meeting
  The 17th Annual General Meeting (AGM) of the Company was held on April 30, 2012. (For more details kindly refer Corporate Announcements on .... (opens in a new tab)
Apr 2012
- 30 Apr · Limited Review for Mar 31, 2012
  Limited Review Report for the period ended March 31, 2012. (For more details kindly refer Corporate Announcements on www.bseindia.com). (opens in a new tab)
- 30 Apr · Meeting
  The 17th Annual General Meeting (AGM) of the Company was held on April 30, 2012. (opens in a new tab)
- 30 Apr · Results
  Results Press Release dated April 30, 2012 for the period ended March 31, 2012. (opens in a new tab)
- 30 Apr · Results
  Financial Results for the period ended March 31, 2012. (opens in a new tab)
- 23 Apr · Disclosure
  Claris Lifesciences Ltd has submitted the disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 (opens in a new tab)
- 23 Apr · Disclosure
  Aditya Handa has submitted the disclosures under Reg.13(4), 13(4A) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 (opens in a new tab)
- 3 Apr · Disclosure
  Aditya Handa has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE: (opens in a new tab)
- 3 Apr · Meeting
  Register of Members & Share Transfer Books of the Company will remain closed from April 24, 2012 to April 30, 2012 (both days inclusive) ....